AMSorb™- Bioresorbable Coronary Drug Eluting Stent System

AMSorb™ is a bioresorbable coronary stent fabricated from medical-grade Poly-L-lactic acid (“PLLA”) polymer utilizing our proprietary 3D-MAP technology, intended for use in PCI procedures to treat obstructive coronary artery disease. Under the 3D-MAP technology, the stent is engineered with round struts featuring circular cross-sections to optimize the stent apposition, enabling smoother embedment into the vessel wall and reducing effective strut thickness compared with conventional laser-cut rectangular struts. This geometric profile delivers hemodynamic benefits by minimizing blood flow disturbance and mechanical damage to blood cells, thereby accelerating endothelialization and reducing the risk of thrombosis while the PLLA matrix undergoes hydrolytic resorption to preserve natural vessel vasomotion.

For more product information, please feel free to contact us.

Consult

Product Features

● New stent manufacturing process with controlled material crystallinity for faster degradation rate

● Patented closed-cell stent design with excellent radial strength and structural stability

● Better stent crossing and delivery performances due to the flexible stent design

● Round stent struts with reduced cross-sectional areas for faster endothelialization and material resorption

Specifications

Stent diameter: 2.5mm~4.0mm

Stent length: 12mm~33mm

Results of AMSorb® FIM Trial 3 Years Follow-up: Restore, Repair and Resorption

Jetfall™- Medical Carbon Dioxide Angiographic Injector and Accessories (for outside US)

JetfallAngio™- Medical CO₂ Management and Transfer System

AMSorb™- Bioresorbable Coronary Drug Eluting Stent System